Vertex Pharma To Acquire ViaCyte For $320 Mln In Cash

Vertex Advances Inaxaplin Into Phase 2/3 Trial To Treat APOL1-Mediated Kidney Disease

Vertex Pharmaceuticals Inc. (VRTX) announced Monday that inaxaplin (VX-147) has advanced into the Phase 3 portion of the global Phase 2/3 pivotal clinical trial in APOL1-mediated kidney disease (AMKD), where a 45 mg once daily oral dose will be compared to placebo, on top of standard of care.

RTTNews | hace 549

Vertex Receives CHMP Positive Opinion For The First CRISPR/Cas9 Gene-Edited Therapy CASGEVY

Vertex Pharmaceuticals Inc. (VRTX) announced Friday that the European Medicines Agency's (EMA's) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for the conditional approval of CASGEVY (exagamglogene autotemcel [exa-cel]), a CRISPR/Cas9 gene-edited therapy, for the treatment of severe sickle cell disease (SCD) and transfusion-dependent beta thalassemia (TDT).

RTTNews | hace 657

Vertex Pharma Inks Licensing Agreement To Use CRISPR Therapeutics' Gene Editing Technology

Biotechnology company Vertex Pharmaceuticals, Inc. (VRTX) and gene editing company CRISPR Therapeutics, Inc. (CRSP) announced Monday that they have entered into a new non-exclusive licensing agreement for the use of CRISPR Therapeutics' gene editing technology, known as CRISPR/Cas9, to accelerate the development of Vertex's hypoimmune cell therapies for type 1 diabetes (T1D).

RTTNews | hace 920

Vertex Pharma Says FDA Lifts Clinical Hold On Phase 1/2 Trial Of VX-880 To Treat Type 1 Diabetes

Vertex Pharmaceuticals Inc. (VRTX) announced Tuesday that the U.S. Food and Drug Administration (FDA) has lifted the clinical hold placed on the Phase 1/2 clinical trial of VX-880, an investigational stem cell-derived, fully differentiated pancreatic islet cell replacement therapy for people with type 1 diabetes (T1D) with impaired hypoglycemic awareness and severe hypoglycemia.

RTTNews | hace 1185

European Economic News Preview: Eurozone Final Composite PMI Due

Final composite purchasing managers' survey results from the euro area and the UK are due on Friday, headlining a busy day for the European economic news. At 2.45 am ET, France's statistical office INSEE publishes industrial production data for August. Output is forecast to rebound 0.3 percent on a monthly basis, following a 1.1 percent drop in July.

RTTNews | hace 19 minutos

Sensex, Nifty Marginally Lower In Early Trade

Indian shares were slightly lower on Friday, after having risen sharply in the previous session on dovish RBI pause.

RTTNews | hace 27 minutos

Australian Market Trims Early Gains In Mid-market

The Australian stock market is trimming its early gains in mid-market moves on Friday, but extending the gains in the previous session, following the broadly positive cues from Wall Street overnight. The benchmark S&P/ASX 200 is moving above the 8,950 level, with gains in financial and technology stocks partially offset by weakness in mining stocks.

RTTNews | hace 1h 31min

Asian Markets Trade Mixed

Asian stock markets are trading mixed on Friday, following the broadly positive cues from Wall Street overnight, with mainland China and South Korean markets closed for holidays. Optimism about the outlook for interest rates and weakening US dollar against major currencies in the region are aiding market sentiment. Asian markets ended mostly higher on Thursday.

RTTNews | hace 2h 1min

EURUSD	1.17189	GBPUSD	1.34358	AUDUSD	0.65916
USDJPY	147.718	USDCAD	1.39679	USDCHF	0.79767